Aveo Pharmaceuticals Inc (AVEO.OQ)

AVEO.OQ on NASDAQ Stock Exchange Global Select Market

1.26USD
3:06pm EDT
Price Change (% chg)

$-0.03 (-2.33%)
Prev Close
$1.29
Open
$1.29
Day's High
$1.31
Day's Low
$1.25
Volume
57,188
Avg. Vol
231,199
52-wk High
$2.49
52-wk Low
$1.00

AVEO.OQ

Chart for AVEO.OQ

About

AVEO Pharmaceuticals, Inc., doing business as AVEO Oncology, is a biopharmaceutical company. The Company is engaged in discovering, developing, and commercializing targeted cancer therapies using its Human Response Platform. Its therapeutic candidates under development program include AV-203, an anti-ErbB3 monoclonal antibody... (more)

Overall

Beta: 0.94
Market Cap (Mil.): $67.42
Shares Outstanding (Mil.): 52.27
Dividend: --
Yield (%): --

Financials

  AVEO.OQ Industry Sector
P/E (TTM): -- 107.05 36.29
EPS (TTM): -1.54 -- --
ROI: -55.67 -0.60 18.13
ROE: -77.29 -1.65 18.95
Search Stocks

Aveo, Astellas end pact to develop cancer drug tivozanib

- Aveo Oncology and Astellas Pharma Inc said they would end an agreement to develop Aveo's lead experimental drug that has seen a string of failures in multiple cancer indications.

14 Feb 2014

UPDATE 1-Aveo, Astellas end pact to develop cancer drug tivozanib

Feb 14 - Aveo Oncology and Astellas Pharma Inc said they would end an agreement to develop Aveo's lead experimental drug that has seen a string of failures in multiple cancer indications.

14 Feb 2014

Aveo, Astellas end pact to develop cancer drug Tivozanib

Feb 14 - Aveo Oncology and Astellas Pharma Inc said they would end an agreement to develop Aveo's lead experimental drug and said they would discontinue a mid-stage study testing its use in colon cancer.

14 Feb 2014

Competitors

  Price Change
Takeda Pharmaceutical Co Ltd (4502.T) ¥4,727 -5.50
DAIICHI SANKYO COMPANY, LIMITED (4568.T) ¥1,884 -3.00
Eisai Co., Ltd (4523.T) ¥4,399 -7.50
Pfizer Inc. (PFE.N) $28.75 -0.51
Novartis AG (NOVN.VX) CHF79.55 -0.80
Roche Holding Ltd. (ROG.VX) CHF264.70 -2.00
Bayer AG (BAYGn.DE) €98.92 -2.08
Bayer AG (BAYE.F) -- --
Sanofi SA (SASY.PA) €78.62 +1.73
AstraZeneca plc (AZN.L) 4,344.50p -13.00

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: New Constructs, LLC
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Pechala's Reports
$25.00
Provider: Pechala's Reports
$15.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks